R. Lohmann

发表

Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.

M. Keeney, D. Allan, R. Lohmann, 2005, Laboratory hematology : official publication of the International Society for Laboratory Hematology.

Flow cytometric reticulocyte analysis using thiazole orange; clinical experience and technical limitations.

M. Keeney, I. Chin-Yee, R. Lohmann, 2008, Clinical and laboratory haematology.

Didemnin B in favourable histology non-Hodgkin's lymphoma

W. Steward, G. Goss, R. Lohmann, 2004, Investigational New Drugs.

Nephrotic Syndrome: A Hypercoagulable State

R. Lohmann, A. Kendall, J. Dossetor, 1971 .

Immunologic findings, thrombocytopenia and disease activity in lupus nephritis.

W. Clark, R. Lindsay, A. Linton, 1978, Canadian Medical Association journal.

Phase II Study of Oral Vinorelbine in First-Line Advanced Breast Cancer Chemotherapy

R. Gascoyne, J. Connors, E. Eisenhauer, 2003 .

Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group.

R. Gascoyne, J. Connors, E. Eisenhauer, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follicular lymphoma: A survey of 75 cases with special reference to the syndrome resembling chronic lymphocytic leukaemia.

E. Wiltshaw, D. Galton, S. Spiro, 1975, The British journal of cancer. Supplement.

Carcinoma of the prostate presenting as acute disseminated intravascular coagulation.

D. Grignon, R. Lohmann, D. Turnbull, 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma

K. Bélanger, E. Eisenhauer, M. Smylie, 2005, Investigational New Drugs.

Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

E. Eisenhauer, W. Walsh, A. Colevas, 2004, Investigational New Drugs.

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

B. Zee, N. Iscoe, I. Quirt, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute non-lymphocytic leukaemia and myelofibrosis following sequential hemibody irradiation for prostatic carcinoma.

A. Porter, I. Chin-Yee, R. Lohmann, 1991, Clinical oncology (Royal College of Radiologists (Great Britain)).

Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group

K. Bélanger, E. Eisenhauer, W. Steward, 2002, Investigational New Drugs.

Oral indomethacin and ranitidine in advanced melanoma: a phase II study.

W. Mertens, R. Lohmann, 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).

Plasma exchange in thrombotic thrombocytopenic purpura.

W. Clark, E. Toffelmire, A. Linton, 1984, Canadian Medical Association journal.

Results of a randomized phase II study of two schedules of bryostatin-I in patients with malignant melanoma: experience with the multivariate stopping rule

K. Bélanger, L. Seymour, B. Zee, 1999 .

A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study

L. Seymour, B. Zee, M. Davis, 2002, Investigational New Drugs.